Literature DB >> 19030375

Is montelukast effective and well tolerated in the management of asthma in young children?: Part A: Evidence-based answer and summary.

Gary M Doherty1.   

Abstract

Entities:  

Year:  2007        PMID： 19030375      PMCID： PMC2528689          DOI： 10.1093/pch/12.4.307

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  13 in total

Review 1.  Leukotriene-receptor antagonists.

Authors:  B J Lipworth
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

2.  The benign clinical course following a large pediatric montelukast ingestion.

Authors:  F Lee Cantrell; Mary Farson-Collier
Journal:  J Toxicol Clin Toxicol       Date:  2004

3.  Montelukast-induced hepatitis.

Authors:  Marc F Goldstein; James Anoia; Martin Black
Journal:  Ann Intern Med       Date:  2004-04-06       Impact factor: 25.391

4.  Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.

Authors:  Janet van Adelsberg; James Moy; Lynn X Wei; Carol A Tozzi; Barbara Knorr; Theodore F Reiss
Journal:  Curr Med Res Opin       Date:  2005-06       Impact factor: 2.580

5.  Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

Authors:  B Knorr; J Matz; J A Bernstein; H Nguyen; B C Seidenberg; T F Reiss; A Becker
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

6.  A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.

Authors:  Hans Bisgaard
Journal:  Am J Respir Crit Care Med       Date:  2002-10-03       Impact factor: 21.405

7.  Response to montelukast among subgroups of children aged 2 to 14 years with asthma.

Authors:  Katie A Meyer; Jean Marie Arduino; Nancy C Santanello; Barbara A Knorr; Hans Bisgaard
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

8.  Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.

Authors:  J P Kemp; R J Dockhorn; G G Shapiro; H H Nguyen; T F Reiss; B C Seidenberg; B Knorr
Journal:  J Pediatr       Date:  1998-09       Impact factor: 4.406

9.  Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.

Authors:  Nancy K Ostrom; Bruce A Decotiis; William R Lincourt; Lisa D Edwards; Kathleen M Hanson; Jacqueline R Carranza Rosenzweig; Courtney Crim
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

10.  Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.

Authors:  Robert S Zeiger; Stanley J Szefler; Brenda R Phillips; Michael Schatz; Fernando D Martinez; Vernon M Chinchilli; Robert F Lemanske; Robert C Strunk; Gary Larsen; Joseph D Spahn; Leonard B Bacharier; Gordon R Bloomberg; Theresa W Guilbert; Gregory Heldt; Wayne J Morgan; Mark H Moss; Christine A Sorkness; Lynn M Taussig
Journal:  J Allergy Clin Immunol       Date:  2006-01       Impact factor: 10.793
View more
  2 in total

Review 1.  Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management.

Authors:  Alan Kaplan; J Mark FitzGerald; Roland Buhl; Christian Vogelberg; Eckard Hamelmann
Journal:  NPJ Prim Care Respir Med       Date:  2020-11-11       Impact factor: 2.871

2.  Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma.

Authors:  Maureen Egan; Supinda Bunyavanich
Journal:  Asthma Res Pract       Date:  2015-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.